Table 1.
Group | Non-PSD | PSD | P-value* |
---|---|---|---|
N | 209 | 154 | |
Age (y), mean ± SD | 62.7 ± 10.5 | 61.9 ± 12.3 | 0.554 |
Gender, male n (%) | 69 (33.2%) | 62 (41.1%) | 0.125 |
BMI (kg/m2) | 24.3 ± 9.2 | 24.1 ± 4.1 | 0.824 |
Education (years) | 4.3 ± 3.9 | 4.0 ± 3.5 | 0.413 |
Lesion location | |||
Frontal lobe, n (%) | 31 (17.5%) | 24 (18.0%) | 0.904 |
Parietal lobe, n (%) | 17 (9.6%) | 11 (8.3%) | 0.685 |
Temporal lobe, n (%) | 12 (6.8%) | 14 (10.5%) | 0.239 |
Occipital lobe, n (%) | 14 (4.5%) | 10 (7.5%) | 0.899 |
Basal ganglia, n (%) | 78 (44.1%) | 75 (56.4%) | 0.032* |
Cerebellum, n (%) | 18 (10.2%) | 16 (12.0%) | 0.604 |
Midbrain, n (%) | 20 (11.3%) | 13 (9.8%) | 0.667 |
Pons, n (%) | 29 (16.4%) | 21 (15.8%) | 0.888 |
Medulla, n (%) | 23 (13.0%) | 40 (12.9%) | 0.956 |
History of drinking, n (%) | 78 (39.2%) | 44 (30.6%) | 0.099 |
History of smoking, n (%) | 66 (31.7%) | 43 (28.7%) | 0.534 |
History of hypertension, n (%) | 150 (72.5%) | 111 (72.5%) | 0.986 |
History of diabetes, n (%) | 42 (20.4%) | 39 (25.5%) | 0.253 |
History of hyperlipidemia, n (%) | 17 (8.3%) | 17 (11.1%) | 0.368 |
Coronary artery disease, n (%) | 18 (8.8%) | 8 (5.3%) | 0.206 |
History of a previous stroke, n (%) | 19 (9.2) | 17 (11.1) | 0.556 |
MMSE, mean ± SD | 22.5 ± 5.5 | 21.1 ± 5.5 | 0.019* |
HAMD, median (IQR) | 3 (1–6) | 6 (3–9) | 0.001* |
NIHSS, median (IQR) | 2 (1–4) | 3.5 (1–6) | <0.001* |
mRS, median (IQR) | 1 (1–3) | 2 (1–4) | <0.001* |
BI, median (IQR) | 95 (65–100) | 60 (40–90) | <0.001* |
Unfavorable outcome at baseline, n (%) | 32 (11.3%) | 51 (33.3%) | <0.001* |
Unfavorable outcome at 5-years, n (%) | 28 (13.4%) | 45 (29.2%) | <0.001* |
BMI, body mass index; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; MMSE, mini mental state examination; BI, modified Barthel Index; IQR, interquartile range; SD, standard deviation; PSD, Post-stroke depression.
p < 0.005.